Ivan Kairatov is a leading biopharma expert with a deep understanding of how generative artificial intelligence is reshaping the landscape of drug development. With extensive experience in research and development, he has been at the forefront of integrating computational biology with traditional
The intricate architecture of the human gut serves as a delicate frontier where trillions of microbes meet the body’s immune system in a constant, silent negotiation for balance. For millions of people living with ulcerative colitis, this internal peace treaty has collapsed, replaced by a
Every thirty seconds, a clinician somewhere in the world stares at a cryptic electrocardiogram, desperately searching for the subtle clues of a hidden heart attack that could cost a patient their life. This high-stakes environment is where the traditional diagnostic framework often falters,
The current landscape of medical technology is undergoing a seismic shift as digital twins evolve from conceptual experimental models into indispensable assets for clinical decision-making and hospital administration. As of 2026, the global market for these virtual replicas has already surpassed
The global healthcare landscape is currently confronting a transformative challenge that necessitates a fundamental shift in how we approach chronic and life-threatening illnesses. With projections from the American Cancer Society suggesting that global cancer cases could reach 35 million annually
Every year, millions of Americans walk into imaging centers to undergo computed tomography scans for specific ailments, yet a staggering amount of life-saving biological data remains completely unread within those digital files. When a physician orders a chest CT to investigate a persistent cough
